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Anergic B cells are characterized by impaired sig-
naling and activation after aggregation of their
antigen receptors (BCR). The molecular basis of
this impairment is not understood. In studies re-
ported here, Src homology-2 (SH2)-containing
inositol 5-phosphatase SHIP-1 and its adaptor Dok-1
were found to be constitutively phosphorylated in
anergic B cells, and activation of this inhibitory circuit
was dependent on Src-family kinase activity and
consequent to biased BCR immunoreceptor tyro-
sine-based activation motif (ITAM) monophosphory-
lation. B cell-targeted deletion of SHIP-1 caused
severe lupus-like disease. Moreover, absence of
SHIP-1 in B cells led to loss of anergy as indicated
by restoration of BCR signaling, loss of anergic
surface phenotype, and production of autoanti-
bodies. Thus, chronic BCR signals maintain anergy
in part via ITAMmonophosphorylation-directed acti-
vation of an inhibitory signaling circuit involving
SHIP-1 and Dok-1.
INTRODUCTION
Remarkably, nearly 70%of newly produced immature B cells are
autoreactive and must be silenced to prevent autoimmunity
(Wardemann et al., 2003). We have recently shown that many
of these cells are silenced by anergy (Merrell et al., 2006). Anergy
is a condition of antigen unresponsiveness that is induced by
chronic autoantigen occupancy of as few as 20% of antigen
receptors (BCR) and can be rapidly reversed by removal of auto-
antigen from the BCR (Gauld et al., 2005; Goodnow et al., 1991).
Curiously, chronically occupied receptors transduce both posi-
tive and negative signals. Reflecting the former, anergic B cells
display a slight elevation (50 nM) in intracellular free calcium
concentration ([Ca2+]i), as well as activation of the transcription
factor NFAT and the tyrosine kinase ERK, that are lost within
a few minutes of autoantigen dissociation from receptors (Gauld
et al., 2005). Other BCR-linked pathways that are associated746 Immunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc.with cell activation, including those involving the signaling
intermediaries Card11, NF-kB, and JNK, are not activated by
chronic BCR occupancy, nor are these triggered by stimulation
of unoccupied BCR on anergic cells (Benschop et al., 2001;
Cambier et al., 2007; Cooke et al., 1994; Erikson et al., 1991;
Gauld et al., 2005; Healy et al., 1997, 1998; Jun and Goodnow,
2003). Furthermore, some responses, e.g., antigen-induced up-
regulation of CD86 expression, are restored after autoantigen
dissociation from receptors (Gauld et al., 2005). These findings
demonstrate that chronically occupied antigen receptors simul-
taneously transduce nondurable signals that stimulate some
pathways that normally emanate from the BCR while inhibiting
others.
Little is known regarding the biochemical nature of inhibitory
signals that are transduced by chronically occupied BCR and
prevent activation of NF-kB, CARD11, and JNK, while allowing
activation of NFAT and ERK. It is possible that the former
responses are limited by the inability to stimulate increased
[Ca2+]i beyond the elevated basal concentrations in anergic cells.
In support of this possibility are findings of Dolmetsch et al.
(1997), which demonstrate that activation of NF-kB requires
greater [Ca2+]i than activation of NFAT. Regulatory mechanisms
that govern calcium mobilization in anergic cells must target
upstream signaling events because calcium store depletion-
induced extracellular influx is intact in anergic cells (Yarkoni
and Cambier, 2011). Consistent with this possibility, a recent
study showed in a transgenic model that in anergic B cells,
BCR stimulation fails to induce normal accumulation of phos-
phatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3), a second
messenger required for phospholipase C (PLCg) signaling and,
in turn, activation of calcium mobilization as well as Card 11,
NF-kB, JNK, and Erk pathways (Browne et al., 2009). These find-
ings suggest that failed generation or increased consumption of
PtdIns(3,4,5)P3 may mediate the unresponsiveness of anergic B
cells. Indeed, Browne et al. (2009) have reported that anergic
anti-hen eggwhite lysoszyme (HEL) (MD4.ML5) B cells express
increased amounts of the inositol lipid phosphatase PTEN that
may consume PtdIns(3,4,5)P3. However, this mechanism would
seem to have durability inconsistent with minute time-scale re-
versibilty of anergy seen in the Ars/A1 immunoglobulin trans-
genic model (Gauld et al., 2005).
Here we report studies that address the basis of regulatory
signaling by chronically occupied antigen receptors by analysis
Figure 1. Chronic Activation of the SHIP-1-
Dok-1 Inhibitory Pathway in Anergic B Cells
(A) B cell lysates (0.5 3 106 cell equivalents) from
the CD43-negative fraction of spleens from kTg or
Ars/A1 (Ars) mice were lysed and immunoblotted
to examine their ex vivo basal expression of
phosphoproteins (pTyr) as well as Syk and Lyn as
loading controls.
(B) Dok-1-sufficient or Dok-1-depleted B cell
lysate samples were probed with pTyr antibodies
to confirm the identity of the elevated pTyr band
in (A), and the immunoprecipitated Dok-1 from
either kTg or Ars B cell lysates is shown on the right
of the blot.
(C) Purified B cells (10 3 106) from MD4 and
anergic MD4.ML5 mice were immunoprecipitated
with anti-Dok and anti-SHIP-1 and probed with
pTyr antibody to examine basal pDok-1 or pSHIP-1
expression.
(D) Purified B cells (10 3 106) from kTg or Ars/A1
spleenswere immunoprecipitatedwith anti-SHIP-1
or anti-CD22 and immunoblots were probed with
anti-pTyr (top), whole cell lysates (106 cell equiv-
alents) were blotted for SHP-1 Y536 and SHP-1
S591.
(E) B cells enriched from spleens of C57BL/6, Ars/
A1, MD4, or MD4.ML5 mice were lysed and im-
munoblotted with anti-PTEN or anti-actin as
a loading control.
Blots are representative of one of at least three
experiments.
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SHIP-1 Is Required for B Cell Anergyof anomalies in protein tyrosine phosphorylation in anergic
cells. Results indicate that chronic BCR occupancy leads to
biased monophosphorylation of the BCR CD79 ITAM motifs,
leading in turn to Src-family kinase-dependent phosphorylation
of the inositol 5-phosphatase SHIP-1 and its adaptor protein
Downstream of kinase (Dok-1). Furthermore, we show that
SHIP-1 is critical for maintenance of anergy. B cell-targeted
SHIP-1 gene ablation restores BCR signaling in anergic cells
and leads to severe, early-onset lupus-like autoimmunity.
These findings indicate that two mechanisms that reduce the
amount of PtdIns(3,4,5)P3 in cells are operative in maintaining
B cell anergy. These include activation of the SHIP-1-Dok-1
circuit, which is seen in MD4.ML5 anti-hen egg lysozyme-hen
egg lysozyme and Ars/A1 anti-DNA transgenic models of
anergy, as well as in naturally occurring An1 (Anergic-1) B
cells, and upregulation of PTEN, which seems to occur uniquely
in cells with very high autoantigen avidity, e.g., MD4.ML5 B
cells.Immunity 35, 746–756, NRESULTS
Increased Tyrosine
Phosphorylation of SHIP-1 and Its
Adaptor Dok-1 in Anergic B Cells
In naive B cells, antigen receptors trans-
duce signals via the proximal activation
of tyrosine kinases, and therefore it
seems plausible that anergy-enforcing
signals transduced in anergic B cells
might also be mediated by tyrosine phos-phorylation, perhaps targeting unique substrates. To explore
this possibility, we compared basal protein tyrosine phosphory-
lation in immediately ex vivo anergic B cells from Ars/A1 mice to
that of naive B cells from animals transgenic for the k light chain
used to construct the Ars/A1 B cell antigen receptor (Benschop
et al., 2001). When whole cell lysates were compared, the most
significant difference seen was increased phosphorylation of
a substrate of a62 kDa protein (Figure 1A). Based on its relative
mass, we hypothesized that this phosphoprotein might be the
adaptor Dok-1 and/or its closely related homolog Dok-3, both
of which are expressed in B cells (Lemay et al., 2000). Further
analysis indicated that this protein was not Dok-3, which
migrates at a distinctly lower relative mass than the phosphopro-
tein observed in anergic cells (Figure S1 available online).
Indeed, when lysates were immunodepleted with an antibody
reactive with Dok-1 prior to analysis, this band was depleted
(Figure 1B, first four lanes), and the immunoprecipitate contained
the 62 kDa phosphoprotein (Figure 1B, lanes 5 and 6). Furtherovember 23, 2011 ª2011 Elsevier Inc. 747
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SHIP-1 Is Required for B Cell Anergyanalysis revealed that Dok-1 phosphorylation was also elevated
in anergic B cells from MD4.ML5 mice (Figure 1C, left). These
findings are consistent with the reported increase in Dok-1 phos-
phorylation in naturally occurring AN1 anergic B cells (Merrell
et al., 2006) and suggests that elevated tyrosine phosphorylation
of Dok-1 is a general feature of anergic B cells.
Dok-1 functions as an adaptor for multiple effectors including
the SH2-containing inositol 5-phosphatase SHIP-1 and ras
GTPase p120 rasGAP (Helgason et al., 1998; Mashima et al.,
2009). In view of a previous report stating that anergic B cells
fail to accumulate PtdIns(3,4,5)P3 after stimulation (Browne
et al., 2009), we were interested in the possible role of SHIP-1,
the dominant SHIP isoform in B cells, in anergy. We found that
in both MD4.ML5 and Ars/A1 anergic B cells, SHIP-1 phosphor-
ylation was elevated relative to controls (Figure 1C, right, and
Figure 1D, left).
The SH2-containing phosphotyrosine phosphatase SHP-1
has also been implicated in regulation of BCR signaling and in
maintenance of tolerance. In this regard, B cell-targeted ablation
of SHP-1 leads to lupus-like disease (Pao et al., 2007). To begin
to explore possible roles in anergy of SHP-1 and immunorecep-
tor tyrosine-based inhibitory motif (ITIM)-containing receptors
that engage this phosphatase, we analyzed tyrosine phosphory-
lation of CD22 (Ferry et al., 2005) and SHP-1 (Liu et al., 2007).
Phosphorylation of CD22 is required for its recruitment of
inhibitory effector molecules (Blasioli and Goodnow, 2002), and
phosphorylation of SHP-1 Y536 and S591 has been shown to
occur rapidly after antigen receptor stimulation (Zhang et al.,
2003; Liu et al., 2007). We did not detect changes in phosphor-
ylation of CD22, or SHP-1 in anergic cells, arguing against their
function in maintaining anergy (Figure 1D).
Recently, the inositol 3-phosphatase PTEN was proposed as
a mediator of the unresponsive state of anergic B cells based
on the fact that its expression is increased in anergic B cells
fromMD4.ML5mice (Browne et al., 2009). To address this possi-
bility further we sought to confirm the findings of Browne and
Rickert (Browne et al., 2009) and extend them to the Ars/A1
model. As shown in Figure 1E, increased PTEN was detected
in anergic MD4.ML5 B cells. However, we detected no increase
in PTEN in anergic Ars/A1 B cells. These findings suggest that
PTEN upregulation may be unique to B cells that are chronically
stimulated by very high avidity autoantigens. Although the affinity
of MD4 anti-HEL for hen egg lysozyme is high (Ka > 23 10
9M1),
the affinity of Ars/A1 BCR for ssDNA, its only known autoantigen,
is much lower (<106 M1).
Consistent with chronic activation of SHIP-1 (and PTEN upre-
gulation in MD4.ML5 mice), basal Akt phosphorylation (as an
indirect measurement of PtdIns(3,4,5)P3 accumulation) was
reduced in anergic cells relative to controls, whereas basal
CD19 phosphorylation was increased (Figure S2). BCR stimula-
tion of phosphatidylinnositol-3 (PI3) kinase is partially dependent
on tyrosine phosphorylation of CD19 (Buhl and Cambier, 1999;
Inabe and Kurosaki, 2002), and anergic B cells receive constant
signals through the BCR because of association with self-
antigen (Gauld et al., 2005). Increased basal phosphorylation
of CD19 in the face of reduced basal activation of Akt is sugges-
tive of chronically increased PtdIns(3,4,5)P3 hydrolysis in anergic
cells rather than decreased PtdIns(3,4,5)P3 production. Addi-
tional aggregation of their BCR led to a modestly reduced748 Immunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc.CD19 phosphorylation in anergic B cells compared to naive cells
and reduced Akt phosphorylation. Taken together these data
support the idea that increased hydrolysis of PtdIns(3,4,5)P3 by
SHIP-1 plays a role in maintaining anergy.
B Cell-Targeted Deletion of SHIP-1 Results in Severe
Lupus-like Autoimmunity
Given the evidence that the SHIP-1 pathway is active in anergic
B cells, we next explored the affect of B cell-targeted Inpp5d
(inositol polyphosphate-5-phosphatase D, ship-1 gene) ablation
on immune tolerance. Mice in which the Inpp5d gene is flanked
by LoxP sites (Karlsson et al., 2003) were crossed to mice ex-
pressing CRE recombinase under control of theCd79a promoter
(Hobeika et al., 2006). As shown in Figure 2A, analysis of splenic
B cells by both anti-SHIP-1 immunoblotting and immunofluores-
cence revealed that SHIP-1 expression is reduced by >90% in
splenic B cells but unchanged in T cells. Thus conditional Inpp5d
gene ablation in these mice is B cell specific and, furthermore,
most SHIP-1 protein decays between the pro-B cell stage,
when the Cd79a promoter is activated, and mature stages.
We next examined the appearance of autoantibodies in mice
in which B cells were ablated for Inpp5d. Chromatin autoanti-
bodies were readily detectable at 8 weeks of age (Figure 2B).
At 20 weeks of age, B cell-targeted Inpp5d/ mice expressed
chromatin antibodies at amounts comparable to those seen in
NZB/NZW mice of the same age. Sera contained anti-nuclear
antibodies (ANA), and therewas clear evidence of IgG deposition
in kidney glomeruli (Figure 2C). Furthermore, mice with B cell-
targeted Inpp5d deletion died at a similar rate as reported for
NZB/NZW (Auborn et al., 2003) with a <40% survival rate at
1 year, compared to 100% survival of mice that maintained
normal SHIP-1 expression.
Weconsidered thepossibility that autoantibodies arise in these
animals because the inhibitory signaling function of FcgRIIB,
which is SHIP-1 dependent (Ono et al., 1996), would be miti-
gated, and Fcgr2b ablation causes a lupus-like autoimmunity in
C57BL/6 mice (Bolland and Ravetch, 2000). It is noteworthy
that studies shown in Figure 2 utilized B cell-targeted Inpp5D
ablation on C57BL/6.129mixed background, a situation in which
Fcgr2b genetically targeted mice do not develop disease (Bol-
land and Ravetch, 2000). Suggestive of an FcR-independent
role for SHIP-1 in anergy, autoantibodies were not detectable
in 8-week-old Fcgr2b/ mice on pure C57BL/6 background,
a time when autoantibodies were readily detected in mixed
background Inpp5Dfl/fl.Cd79a-cre mice (Figure 2B). Further,
a recent study showed that conventional Inpp5D/ BALB/c
mice produce anti-nuclear autoantibodies by 30 weeks of age,
whereas Fcgr2b/BALB/cmice do not produce autoantibodies
at any age (Bolland and Ravetch, 2000; Maxwell et al., 2011).
This finding lends further support to the contention that
FcgRIIB-independent SHIP-1 functionsmaintainBcell tolerance.
B cell SHIP-1 deficiency might be expected to compromise
tolerance to all self-antigens. To explore the possibility that
autoantibodies of additional specificities are made in the condi-
tionally ablated mice, we analyzed sera from 20-week-old B cell-
targeted Inpp5d/ mice using an autoantigen array (Li et al.,
2007). Autoantibodies produced were restricted to specificities
seen in lupus, with the strongest reactivities detected against
ssDNA, dsDNA, dsRNA, and chromatin (Figure 2D). Thus
Figure 2. Specific Loss of SHIP-1 in the B Cell Compartment of Inpp5dfl/fl.Cd79a-cre Mice Induces Autoimmunity In Vivo
(A) B cell lysates from Inpp5d/, Inpp5dfl/fl.Cd79a-cre (two mice shown), or Inpp5dfl/fl.Cd79a-WT mice were examined for SHIP-1 protein expression by
immunoblotting with an anti-SHIP-1 or actin as a loading control. B cells were separately examined by flow cytometry for intracellular SHIP-1 (bottom); B cells
(B220+) or T cells (CD3+) were gated. Inpp5d/ (blue filled), Inpp5dfl/fl.Cd79a-cre (red), Inpp5d fl/fl.Cd79a-WT (black).
(B) Anti-chromatin (IgG) ELISAs were used to assess serum autoantibody in young (6- to 8-week-old) or older (20-week-old) Inpp5dfl/fl.Cd79a-cre (red),
Inpp5dfl/fl.Cd79a-WT (black), or Fcgr2b/ (blue) mice (mean value ± SEM). NZWxNZB F1 5-month-old mice (purple) were used as a positive control. Data from
individual mice are plotted in the top panels. n = 7–10 mice/group.
(C) Survival curve plotted for Inpp5dfl/fl.Cd79a-cre or Inpp5dfl/fl.Cd79a-WT mice (top left). Anti-nuclear antibody (ANA) production in 5-month-old
Inpp5dfl/fl.Cd79a-WT or Inpp5dfl/fl.Cd79a-cremice (bottom left). Kidney sections were probedwith a fluorescent anti-IgG to detect IgG deposition in the glomeruli
of either 4-month-old Inpp5dfl/fl.Cd79a-WT or Inpp5dfl/fl.Cd79a-cre mice; H&E stains of consecutive sections (right).
(D) An antibody array was utilized to detect serum autoantibodies in 5-month-old Inpp5dfl/fl.Cd79a-cre or Inpp5dfl/fl.Cd79a-WTmice, n = 3 of each mice. Relative
autoantibody is expressed as a fold increase in Inpp5dfl/fl.Cd79a-cre serum compared to Inpp5dfl/fl.Cd79a-WT control mice (mean value ± SEM).
Data are representative of three (A–C) or two (D) independent experiments.
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Figure 3. Exclusive Deletion of Inpp5d in B
Cells Reverses Their Anergic Phenotype
(A) Bone marrow chimeras were generated and
resulted in the following reconstitution ratio:
Ars.Inpp5dfl/fl.Cd79a-cre (2.7%), C57BL/6
(97.3%) (red), and Ars.Inpp5dWT.Cd79a -cre
(4.9%), C57BL/6 (95.1%) (black). Thesemice were
evaluated at 5 months after bone marrow transfer
for the production of serum autoantibody (IgMa
anti-arsonate) by ELISA (mean value ± SEM).
(B) B cells derived from C57BL/6 (black filled),
Ars/A1 (blue), Ars.Inpp5dWT.Cd79a-cre (black), or
Ars.Inpp5dfl/fl.Cd79a-cre (red) mice were evalu-
ated for surface phenotype by flow cytometry.
(C) Intracellular calcium mobilization was deter-
mined in B220+ B cells from Ars.Inpp5dWT.Cd79a-
WT (green), Ars.Inpp5dfl/fl.Cd79a-cre (blue), or
Ars.Inpp5dWT.Cd79a-cre (red) mice stimulated
with 10 mg/ml anti-IgG (H+L) F(ab0)2.
(D) Purified B cells from Ars.Inpp5dfl/fl.Cd79a-WT
or Ars.Inpp5dfl/fl.Cd79a-cre mice were stimulated
(0, 1, or 5 min) with 10 mg/ml anti-IgG (H+L) F(ab0)2,
and lysates were immunoblotted with anti-pAkt
(S473), or anti-pan Akt antibody.
Data are representative of at least two experi-
ments.
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SHIP-1 Is Required for B Cell Anergyautoantibodies are produced selectively against autoantigens
that carry linked ligands for toll-like receptors (TLRs) 7 and 9.
These findings suggest that in normally silenced autoreactive B
cells, SHIP-1 may function to inhibit BCR signals required to
complement TLR signaling in B cell activation.
SHIP-1 Is Required to Maintain B Cell Anergy
Inpp5d deletion could subvert tolerance by allowing autoreactive
cells to evade receptor editing, deletion, or anergy. To begin to
explore these possibilities, we analyzed the effect B cell-
targeted Inpp5d ablation on anergy in Ars/A1 transgenic mice
(Ars.Inppd5fl/fl.Cd79a-cre) and Inpp5d-sufficient controls
(Ars.Inpp5dWT.Cd79a-cre). Because immune tolerance to
ssDNA required that B cells express SHIP-1 (Figure 2), we
thought that anergy of Ars/A1 B cells might be disrupted in the
absence of SHIP-1. In Ars/A1 mice in which B cells lacked
SHIP-1, peripheral B cell numbers were reduced by70%, sug-
gesting enhanced negative selection (data not shown). Because
these mice are conventional Ig transgenics and are therefore
unable to undergo receptor editing, this presumably reflects
increased clonal deletion. Increased sensitivity to deletion is
consistent with removal of a negative regulator of BCR signaling.
Based on this result, one might have expected that the tolerance
of this clonotype might be better enforced in the conditionally
ablated mice. However, as discussed below this is not the case.
Analysis of autoantibody production in B cell-targeted
Inpp5d/ mice revealed loss of tolerance (Figures 2B and 2D).
By 20weeks of age, Ars/A1.Inpp5d/fl/fl.Cd79a-cremice sponta-
neously expressed 4-fold increased autoantibody relative to
Inpp5d-sufficient littermates (data not shown). The seemingly
modest increase in autoantibody in the conditionally targeted
mice was somewhat surprising, and we considered the possi-
bility that autoantibody production or detection might be limited
by antigen neutralization. To test this possibility, we created750 Immunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc.bone marrow chimeric mice in which3%–5% of splenic B cells
were derived from Ars/A1 Inpp5d-sufficient or conditional
Inpp5d/ Ars/A1 mice, whereas the remainder of the repertoire
was diverse. As shown in Figure 3A, by 20 weeks after bone
marrow reconstitution, Inpp5d/ Ars/A1 B cells gave rise
to >100-fold more autoantibody than Ars/A1 Inpp5d-sufficient
control mice.
To more directly address the anergic status of the B cells in B
cell-targeted Inpp5d/ Ars/A1 mice, we analyzed their surface
phenotype. Cell surface mIgM and mIgD were reduced 50% in
conditionally Inpp5d-deleted ex vivo B cells relative to anergic
B cells from Ars/A1.Inpp5dWT.Cd79a-cre mice (Figure 3B). This
effect was consistent with continued in vivo exposure to antigen
and resultant BCR modulation from the cell surface. Consistent
with loss of anergy, Inpp5d -deficient B cells expressed reduced
CD93, CD95, and CD80, the expression of which is normally
increased in anergic B cells (Borrero and Clarke, 2002; Merrell
et al., 2006). Thus the surface phenotype of ex vivo B cells
from conditional Inpp5d/ Ars/A1 mice was indicative of loss
of anergy. Further analysis revealed an increase in frequency
of Ars/A1 B cells with activated phenotype (CD86+) (3.6% versus
0.93% of B cells) in Inpp5d-deleted versus -sufficient B cells.
Similarly, we detected an increased frequency of Ars/A1 plasma
cells (identified as CD138+, intracellular Ars/A1 idiotypehi) in the
Inpp5d-deficient Ars/A1 population (4.96% of B cells) compared
to Inpp5d-sufficient Ars/A1 B cells (0.04%).
To address BCR signaling function in Inpp5d-deficient B cells
from the Ars/A1 mice, we analyzed their ability to mobilize
calcium in response to coaggregation of mIgM and mIgD via
F(ab0)2 anti-mouse H and L chain antibodies. B cells lacking
SHIP-1 mounted robust calcium mobilization responses relative
to anergic control populations (Figure 3C). We further examined
Akt activation in response to BCR ligation with antibody. Condi-
tionally Inpp5d-deleted Ars/A1 B cells underwentmore rapid and
Immunity
SHIP-1 Is Required for B Cell Anergyrobust Akt phosphorylation than anergic controls. Furthermore,
these cells exhibited a >5-fold increase in basal Akt phosphory-
lation consistent with functional autoantigen-induced BCR
signaling in vivo. Taken together, these findings indicate that
ssDNA-reactive Ars/A1 B cells lacking SHIP-1 lose features of
anergy (including antigen unresponsiveness measured by BCR
aggregation-induced Akt activation and calcium mobilization)
and autoantibody production. Importantly, however, because
virtually all peripheral B cells lose phenotypic features of anergy
but only a small proportion proceed to the plasma cell stage,
additional compromising events must be required to fully break
anergy.
BCR Signaling in Anergic B Cells Drives ITAM
Monotyrosylphosphorylation and Inhibitory Signaling
We then explored upstream BCR signaling events that might
bias downstream responses toward activation of the SHIP-1-
Dok-1 inhibitory signaling circuit. The CD79a and b (Ig-a/b)
subunits of the BCR each contain an immunoreceptor tyro-
sine-based activation motif (ITAM) with two conserved
embedded tyrosine residues. We have previously shown that
dual phosphorylation of these ITAMs is required for engagement
of the Syk tyrosine kinase and stimulation of B cell activation
(Kurosaki et al., 1995). It is known that Syk activation is lost in
anergic cells (Cooke et al., 1994; Vilen et al., 1997). Therefore,
we considered the possibility that chronic BCR signals are medi-
ated by ITAM monophosphorylation and that these promote
activation of the SHIP-1-Dok-1 circuit. Consistent with this
possibility, monophosphorylation of ITAM tyrosines appears
sufficient to promote activation of Lyn and possibly other Src-
family kinases (Pao et al., 1998) and Lyn is required to maintain
B cell tolerance to dsDNA (Chan et al., 1997). Thus, ITAMmono-
phosphorylation could, in part by further stimulating Src kinase
activity, propagate signals that maintain anergy.
To explore this possibility, we first assessed basal ITAM
phosphorylation in anergic cells, analyzing in particular the
relative amount of dual phosphorylation versus monophosphor-
ylation of ITAM tyrosines. Because phosphorylation-dependent
anti-CD79a and anti-CD79b ITAM tyrosine antibodies useful in
immunoblotting are not available, we approached the problem
by far western blotting (Wienands et al., 1995). Specifically, we
used the Lyn SH2 domain and the Syk (SH2)2 domain to probe
electrophoretic transfers of SDS-PAGE-fractionated CD79
coimmunoprecipitated with IgM from naive and anergic (Ars/
A1) B cells. The Lyn SH2 binds all phosphorylated ITAM tyro-
sines whereas the Syk (SH2)2 binds only dually phosphorylated
ITAMs (Adachi et al., 2007). This allowed estimation of total
versus dual ITAM phosphorylation. As shown in Figure 4A,
CD79a in anergic B cells exhibited increased basal ITAM phos-
phorylation relative to naive cells as detected by binding of the
Lyn SH2 probe. Dual CD79a tyrosine phosphorylation (as de-
tected by binding of the (SH2)2-Syk-GST recombinant protein
to the blot) was detected in lysates from unstimulated naive
(k only tg) B cells but not in anergic Ars/A1 B cells, indicating
that the increased basal CD79a ITAM phosphorylation in anergic
cells is monophosphorylation. Phosphorylation of CD79b, which
is normally low relative to CD79a, was not detected in these
experiments (data not shown). Thus anergic B cells display
elevated antigen receptor ITAM monophosphorylation.IIn this experiment we also assessed the ability of further BCR
stimulation to induce CD79 phosphorylation in anergic cells.
Interestingly, BCR stimulation led to additional CD79a mono-
phosphorylation but little dual phosphorylation. Phosphorylation
of CD79b was not detected (data not shown). Thus, anergic B
cells have increased basal ITAMmonophosphorylation, presum-
ably driven by chronic autoantigen stimulation, and upon further
BCR stimulation, ITAMs undergo additional mono- but not dual
phosphorylation.
It is unclear what molecular mechanism could limit ITAM
phosphorylation in anergic cells. However, one possibility is
suggested by the recent demonstration that antigen receptor
stimulation can lead to serine phosphorylation of CD79a serine
197 and that this phosphorylation limits output of calcium signals
by the receptor (Heizmann et al., 2010). Given the proximity of
S197 to Y193 in the CD79a ITAM, we thought that S197 phos-
phorylation might occur chronically in anergy cells and might
limit CD79a ITAM tyrosine phosphorylation. Seemingly inconsis-
tent with this possibility is evidence that S197 phosphorylation is
mediated by Syk, which is not activated in anergic cells. Despite
this, we analyzed S197 phosphorylation in naive and anergic B
cells by immunoblotting. Similar S197 phosphorylation was de-
tected in unstimulated naive and anergic cells when the phos-
phatase inhibitor calyculin was used to stabilize phosphor-serine
(pS197) (Figure 4B). Chronically autoantigen stimulated anergic
B cells did not contain elevated pS197, and thus S197 phosphor-
ylation can explain neither their unresponsiveness nor their
chronic ITAMmonophosphorylation. Interestingly, BCR stimula-
tion led to S197 phosphorylation in naive cells but not in anergic
B cells. This finding, as well as failure of BCR stimuli to induce
ITAM biphosphorylation in anergic cells, is consistent with
previous work showing impaired Syk activation in anergic B cells
(Noorchashm et al., 1999).
To address the possibility that monophosphorylation of ITAM
tyrosines is a driver of activation of the SHIP-1-Dok-1 circuit, we
employed previously characterized chimeric receptors
composed of I-Ak a and b extracellular and transmembrane
domains fused to the cytoplasmic tails of CD79a or CD79b,
respectively (Pao et al., 1998). Each chimeric chain was ex-
pressed with a tailless complementary chain to construct surro-
gate receptors that contained one CD79a or one CD79b tail.
These chimeras were expressed in the M12 B cell lymphoma
(I-Ad), and resultant I-Ak-positive lines were stimulated with bio-
tinylated anti-I-Ak and avidin. By systematically mutating the
ITAM tyrosines to phenylalanine, we were able to titrate the
affects of ITAM mono- and biphosphorylation on downstream
signaling. Aggregation of the wild-type CD79 ITAMs led to tyro-
sine phosphorylation of many downstream proteins including
Syk, SHIP-1, and Dok-1 (Figure 4C). In contrast, aggregation of
ITAMs containing only a single motif tyrosine led to very limited
downstream phosphorylation. Importantly, monophosphoryla-
tion was associated with phosphorylation of SHIP-1 and Dok-1
but, as expected, not Syk. Stimulation of SHIP-1 and Dok-1
phosphorylation required that only a single conserved ITAM
tyrosine be present, suggesting that their activation may be
mediated by increased Src-family kinase activation afforded by
ITAM monophosphorylation (Pao et al., 1998). The response
was most obvious with the CD79a ITAM containing tyrosine
182, but was also noted with tyrosine 193. Tyrosine 182 is themmunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc. 751
Figure 4. Increased ITAM Monophosphorylation May Transduce an
Inhibitory Signal in Anergic B Cells
(A) The CD79a and CD79b subunits of the BCR each contain an ITAMwith two
tyrosine residues. We used the Lyn SH2 domain and the Syk (SH2)2 domain as
probes in a far western assay of CD79a and CD79b coimmunoprecipitated
with surface IgM from naive kTg and anergic Ars/A1 B cells. The Lyn SH2
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752 Immunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc.preferred Lyn substrate in CD79a and thus is most likely to be
phosphorylated in anergic B cells (Pao et al., 1998). Similar tyro-
sine dependency was seen with I-Ak CD79b chimeric receptors.
However, greater SHIP-1 and Dok-1 activation occurred when
only tyrosine 195 was present than when only tyrosine 206 was
present, consistent with earlier findings that tyrosine 195 is the
preferred site of CD79b phosphorylation (Pao et al., 1998). Taken
together, these findings demonstrate that chronic antigen
stimulation of anergic B lymphocytes leads to biased BCR
ITAM monophosphorylation and this monophosphorylation
drives activation of the SHIP-1-Dok-1 inhibitory circuit, probably
through activation of Src-family kinases.Chronic BCR-Mediated SHIP-1 Phosphorylation in
Anergic B Cells Is Src-Family Kinase Dependent
Previous findings have demonstrated that in normal B cells,
activation of SHIP-1 and Dok-1 tyrosine phosphorylation by
coaggregation of BCR and FcgRIIB is Lyn dependent (Malbec
et al., 1998). It therefore seems likely that SHIP-1 and Dok-1
phosphorylation in anergic B cells is also Src-family kinase
dependent. To address this hypothesis, we treated ex vivo Ars/
A1 splenic B cells with the Src family kinase inhibitor PP2 and as-
sessed the affect on SHIP-1 phosphorylation (Figure 4D). As
shown, the Src-family tyrosine kinase inhibitor but not the
MEK1 and MEK2 inhibitor blocked basal SHIP-1 tyrosine phos-
phorylation. These data are consistent with a mechanism
wherein chronic BCR stimulation leads to biased Lyn-mediated
receptor ITAM monophosphorylation, leading in turn to activa-
tion of SHIP-1 and Dok-1. However, they do not formally exclude
the action of other Src-family kinases in this pathway.DISCUSSION
In this study we explored the nature of signals that emanate
from chronically occupied BCR on anergic B cells, and the role
such signals play in maintaining unresponsiveness to antigen.
We showed that in anergic B cells, antigen receptor ITAMs
are tyrosine monophosphorylated and that further stimulation
of these cells leads to additional mono- but not dual-tyrosineprotein domain binds all phosphorylated ITAM tyrosines while the Syk (SH2)2
binds only dually phosphorylated ITAMs.
(B) 107/ml kTg and Ars/A1 B cells were incubated for 17minwith 50 nM calyclin
A, 20 mg/ml F(Ab0)2 anti-IgM, both, or no stimulation. WCLs were probed with
antibodies against CD79a S197 and total CD79.
(C) The cytoplasmic tail of CD79a or CD79b was fused to the extracellular
domain of the MHC class II (I-Ak) alpha or beta chains, then expressed in B
cell lymphoma lines. Either one or both ITAM tyrosines from each chimeric
receptor were mutated to phenylalanine to assess the affect of mono-
phosphorylation after receptor aggregation via anti-MHC class II (I-Ak)
antibodies. B cells expressing I-Ak-CD79a or I-Ak-CD79b chimeric receptors
with or without single or double mutations in the ITAM tyrosines within the
cytoplasmic tails were treated with biotin-anti-I-Ak and crosslinked at 37C
with streptavidin. Lysates were used for immunoprecipitation with anti-Syk,
anti-SHIP-1, or anti-Dok-1 beads and immunoblotting was done with anti-pTyr
(4G10), anti-Syk, anti-SHIP-1, and anti-Dok-1.
(D) Purified B cells were incubated with or without inhibitors (PP2, 10 mM;
PD98059, 20 mM) for 30 min at 37C and lysed. Lysates were used for
immunoprecipitation with anti-SHIP-1 beads and immunoblotting was done
with anti-pTyr (4G10) and anti-SHIP-1.
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gic cells the adaptor Dok-1 and its binding partner SHIP-1 are
tyrosine phosphorylated, a condition associated with activation
of their inhibitory signaling function (Ono et al., 1996; Tamir
et al., 2000), and that this can be a consequence of receptor
ITAMmonophosphorylation and activation of Src-family tyrosine
kinases, e.g., Lyn. Finally we showed that disabling this inhibitory
circuit by B cell-targeted deletion of Inpp5d leads to loss of the
anergic phenotype and to development of severe lupus-like
autoimmunity. Taken together, these findings demonstrate that
a consequence of chronic occupancy of antigen receptors on
anergic B cells is ITAM monophosphorylation, and this mono-
phosphorylation drives the activation of inhibitory signaling
circuitry involving the inositol lipid phosphatase SHIP-1 and its
adaptor Dok-1. Activation of this signaling circuit is critical for
prevention of autoimmunity. It is noteworthy that this bias toward
inhibitory signaling is seen in both extant immunoglobulin
transgenic models of anergy, Ars/A1 and MD4.ML5, as well as
in naturally occurring anergic cells (Merrell et al., 2006), and it
is therefore likely that activation of this mechanism is a common
feature of anergic B cells.
The observations raise multiple important questions regarding
maintenance of anergy, including how in molecular terms recep-
tors are rewired to activate ITAM monophosphorylation but not
biphosphorylation; how monophosphorylated ITAMs recruit the
Dok-1 and SHIP-1 circuit; and finally whether and how this
biased proximal signaling signature contributes to the previously
described anergy-associated pattern of downstream events.
It is fair to say that we understand very little regarding how in
anergic B cells antigen receptor signaling is biased toward
receptor ITAM monophosphorylation. Earlier reports showed
that antagonist peptides can induce partial T cell receptor
(TCR) zeta chain ITAM tyrosine phosphorylation (Kersh et al.,
1999). Thus, altered patterns of ITAM phosphorylation can be
determined by both affinity of antigen-receptor interactions
(T cells) as well as chronicity of stimulation (B cells), as shown
here. Parenthetically, incomplete phosphorylation of both BCR
and TCR ITAMs has been shown previously to lead to generation
of inhibitory signals, but the nature of these signals had been
unknown (Kersh et al., 1999; Pao et al., 1998). A basis for altered
antigen receptor coupling to ITAM phosphorylation is suggested
by findings that BCR on anergic B cells are structurally destabi-
lized, resulting in inefficient coimmunoprecipitation after deter-
gent lysis (Vilen et al., 1999). Receptors in which this destabilized
state is approximated by introduction of mutations in the trans-
membrane domains of membrane immunoglobulin heavy chains
are functionally defective (Grupp et al., 1993). Consistent with
the degree of receptor occupancy needed to maintain anergy,
B cells in which as few as 15%–20% of BCR are disabled by
such mutations display reduced receptor tyrosine phosphoryla-
tion and calcium mobilization in response to antigen stimulation
(Vilen et al., 2002). Thus, bias toward receptor monophophoryla-
tion may be the result of poor quality of antigen receptor aggre-
gates consequent to short receptor dwell time or destabilization.
Another possibility is suggested by observations that antigen
receptors on anergic B cells are endocytosed at a greatly
accelerated rate upon antigen binding (Ble´ry et al., 2006). This
could result in premature termination of signaling leaving ITAMs
incompletely phosphorylated. Other findings suggest a role forIinhibitory BCR coreceptors such as CD72 and CD22, which
function by recruiting SHP-1, in maintaining anergy, because
genetically targeted mice lacking these molecules exhibit an
autoimmune phenotype (Li et al., 2008; O’Keefe et al., 1999;
Pao et al., 2007; Shultz et al., 1984). Active SHP-1 could, by
differentially dephosphorylating ITAMs (Veillette et al., 2002),
tip the balance toward monophosphorylation. We note,
however, that, as shown here, we have been unable to detect
increased SHP-1 activation in anergic B cells. Clearly, this is
an important area for future study.
A molecular basis for monophosphoryl-ITAM activation of the
SHIP-1-Dok-1 circuit is suggested by previous findings that
SHIP-1 binds via its SH2 domain to monophosphorylated
FcεR1 beta chain (Kimura et al., 1997) and DAP12 (Peng et al.,
2010). This could lead to SHIP-1 phosphorylation by Src-family
kinases as occurs during FcgRIIB activation and to subsequent
recruitment of Dok-1 (Tamir et al., 2000), which is in turn phos-
phorylated. Dok-1 contains a pleckstrin homology domain (PH)
and a phosphotyrosine binding (PTB) domain and has several
tyrosines in its COOH-terminal region that are phosphorylated
(Mashima et al., 2009; Tamir et al., 2000). These phosphoryla-
tions allow Dok-1 to act as an adaptor for proteins including
p120 rasGAP (via the YXXP motif), SHIP-1, Nck, and Csk (Ma-
shima et al., 2009). Although multiple Dok-1-coupled pathways
may thus be activated in anergic cells, the effect of SHIP-1
knockout suggests that this particular Dok-1 effector may play
a uniquely important role in maintaining anergy. It is noteworthy
that Dok-1 knockout mice do not exhibit autoimmunity (J.C.C.,
unpublished), presumably because of expression of redundant
proteins including Dok-1 z Dok-3 > > Dok-2 (Lemay et al.,
2000; J.C.C., unpublished). Mice in which both Dok-1 and
Dok-2 are ablated (in all cells) suffer lupus-like disease (Yasuda
et al., 2007). Further studies are needed to test the role of other
Dok effectors in anergy.
The mechanism by which SHIP-1 and Dok-1 cooperate to
maintain anergy is suggested by findings that after cell stimula-
tion, Dok-1 is translocated to the plasma membrane via
a PI3K-dependent mechanism (Zhao et al., 2001). Further, this
translocation is mediated by its PH domain. SHIP-1 and Dok-1
associate via SHIP-1 SH2 interaction with phosphotyrosines in
pDok-1 and Dok-1 PTB interactions with phosphotyrosines in
pSHIP-1, presumably forming a bidentate complex (Tamir
et al., 2000). Thus it seems logical that the function of pDok-1
in this context is to target associated pSHIP-1 to areas of the
plasma membrane that are enriched in PtdIns(3,4,5)P3, a SHIP-1
substrate. Dok targeting of SHIP-1 would promote hydrolysis
of PtdIns(3,4,5)P3, thereby limiting the translocation of Bruton’s
tyrosine kinase (BTK) and phospholipase C (PLCg2) to the
plasma membrane, which would consequently block calcium
mobilization. It is possible that PtdIns(3,4,5)P3 depletion also
causes the previously reported BCR destabilization (Vilen
et al., 1999), as well as biased CD79a monophosphorylation
seen in anergic B cells. Ongoing studies in our laboratory
address this hypothesis.
Loss of anergy in B cell-targeted SHIP-1 knockout mice
provides evidence of the central importance of the suppression
of the PtdIns(3,4,5)P3 pathway in anergy. Consistent with this
concept are previously reported findings that mice haploinsuffi-
cient in the PTEN gene spontaneously develop lupus-likemmunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc. 753
Immunity
SHIP-1 Is Required for B Cell Anergyautoimmunity (Di Cristofano et al., 1999). Homozygous knockout
of PTEN might be expected to oppose the anergy-maintaining
effects of SHIP-1 by further increasing PtdIns(3,4,5)P3 amounts.
However, this does not occur, apparently because of require-
ments for PTEN for expression and/or function of activation-
induced cytidine deaminase (Suzuki et al., 2003). Further linking
reduction of PtdIns(3,4,5)P3 to maintenance of anergy are
observations of Browne et al. (2009) that PTEN expression is
increased in anergic B cells from HEL-anti-HEL (MD4.ML5)
transgenic mice. Importantly, however, as shown here, anergic
Ars/A1 B cells do not express elevated PTEN. Interestingly,
studies by Moody et al. (2003) have shown that haploinsufficien-
cies of both PTEN and SHIP-1 lead to more pronounced lupus-
like autoimmunity than either single haploinsufficiency. This
suggests that PTEN upregulation and SHIP-1 activation may
act cooperatively, where SHIP-1 provides rapidly inducible and
reversible regulation while PTEN effects, determined by expres-
sion, might be more durable. Differential use of these mecha-
nisms could explain why autoantigen removal from Ars/A1 B
cells causes reversal of anergy in minutes whereas in the
MD4.ML5 model it requires many (48) hours (Gauld et al.,
2005; Goodnow et al., 1991). Finally, elevation of PTEN may be
involved in maintenance of anergy only in B cells that interact
with high-avidity autoantigens.
How could decreased accumulation of the PtdIns(3,4,5)P3
relate to the unique pattern of transcription factor activation
previously described in anergic B cells (Healy et al., 1998)? It is
well established that in ex vivo B cells, antigen receptor-
mediated PLCg activation and consequent calcium mobilization
are dependent on PtdIns(3,4,5)P3 generation. Dolmetsch et al.
(1997) have shown that downstream signaling pathways
emanating from the BCR are differentially activated depending
on calcium signal amplitude, e.g., activation of NFAT requires
less elevation of [Ca2+]i than activation of NF-kB. Thus, in anergic
cells, reduced PtdIns(3,4,5)P3 could be expected, by limiting
PLCg hydrolysis of PtdIns(4,5)P2, to cause the differential loss
of NF-kB activation relative to NFAT. This mechanism may also
explain loss of CARD11 activation in anergic cells, because
this response is dependent on PKCb activation, which is in turn
dependent on PLCg-mediated generation of diacyglycerol.
Finally, JNK activation, also lost in anergic cells, is negatively
regulated by SHIP-1, linking its regulation to availability of
PtdIns(3,4,5)P3 (Robson et al., 2004). Quantitatively distinct
requirements of NFAT, NF-kB, JNK, and CARD11 pathways for
PtdIns(3,4,5)P3 may explain why some (e.g., NFAT) are spared
in anergic cells, whereas others are not.
EXPERIMENTAL PROCEDURES
Mice
Except where otherwise indicated, 6- to 12-week-old mice were used for all
experiments. Ars/A1 (Benschop et al., 2001), kTg (Benschop et al., 2001),
Fcgr2b/ (Takai et al., 1996), Inpp5d/ (Helgason et al., 1998), MD4, and
MD4.ML5 (Goodnow et al., 1988) mice have been described previously. To
create mice in which SHIP-1 deficiency is restricted to the B cell lineage,
mice with ‘‘floxed’’ Inpp5d (Karlsson et al., 2003) were crossed with mice in
which cre was targeted into the Cd79a locus (Cd79a-cre) (Hobeika et al.,
2006). These mice were kept on a mixed background and are described in
more detail in the Supplemental Information. All experiments with mice were
performed in accordancewith the regulations andwith the approval of National
Jewish Health (Denver, CO) and Institutional Animal Care and Use Committee.754 Immunity 35, 746–756, November 23, 2011 ª2011 Elsevier Inc.B Cell Purification
Untouched resting B cells were isolated by depletion of CD43+ cells with anti-
CD43-conjugated magnetic beads (MACS anti-mouse CD43; Miltenyi Biotec).
B cells were >97% pure by B220+ staining followed by FACS analysis.
Flow Cytometry
Cells were resuspended in PBS containing 1% FCS and 0.05% sodium azide
and incubated with an optimal amount of biotinylated or directly labeled
antibodies described in the Supplemental Information. Cells were analyzed
on a FACSCaliber or LSRII flow cytometer (BD).
Analysis of Calcium Mobilization
B220-stained splenocytes were loaded with Indo-1 acetoxymethyl (Indo1-AM)
(Molecular Probes) and stimulated with 10 mg/ml rabbit anti-mouse IgG (H+L)
F(ab0)2 (Zymed) as described in the Supplemental Information.
Analysis of Protein Phosphorylation
Purified B cells were lysed in 1% NP-40 lysis buffer. Whole cell lysates
were directly mixed with SDS reducing sample buffer or used for immunopre-
cipitation (IP). Detailed description of IPs, inhibitors used, the far western
protocol and the antibodies use for detection after immunoblot are given in
the Supplemental Information.
Cell Lines
Construction of the MHC class II (I-Ak a and b extracellular domains)-CD79a
and CD79b (cytoplasmic tails) fusion proteins and culture conditions for the
M12G3R mouse B cell lymphoma lines expressing these proteins has been
described previously (Pao et al., 1998).
Enzyme-Linked Immunosorbent Assay
Anti-chromatin IgG and anti-Ars IgMa were detected by standard ELISAs,
described in the Supplemental Information.
ANA Detection
Mouse sera were hybridized to HEp-2 antigen substrate slides (BION) and
bound IgG was visualized as described in the Supplemental Information.
Immunohistochemistry
Kidneys were flash frozen in Tissue-Tek OCT embedding media (Sakura) and
4 mm sections were stained for IgG as described in the Supplemental Informa-
tion. Consecutive slides were stained with H&E via standard procedures.
Autoantibody Array
Autoantibodies were measured on an autoantigen proteomic array that has
been described previously (Li et al., 2007) and is described in the Supple-
mental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
immuni.2011.10.011.
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